ES2103347T3 - Utilizacion de dicarbamato de 2-fenil-1,3-propanodiol en el tratamiento de enfermedades neurodegenerativas. - Google Patents

Utilizacion de dicarbamato de 2-fenil-1,3-propanodiol en el tratamiento de enfermedades neurodegenerativas.

Info

Publication number
ES2103347T3
ES2103347T3 ES92307952T ES92307952T ES2103347T3 ES 2103347 T3 ES2103347 T3 ES 2103347T3 ES 92307952 T ES92307952 T ES 92307952T ES 92307952 T ES92307952 T ES 92307952T ES 2103347 T3 ES2103347 T3 ES 2103347T3
Authority
ES
Spain
Prior art keywords
phenyl
propanodiol
dicarbamate
treatment
neurodegenerative diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92307952T
Other languages
English (en)
Inventor
Robert Duane Sofia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharmaceuticals Inc
Original Assignee
Carter Wallace Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carter Wallace Inc filed Critical Carter Wallace Inc
Application granted granted Critical
Publication of ES2103347T3 publication Critical patent/ES2103347T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EL USO DE DICARBONATO DE 2 RA LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO Y CONTROL DE LOS SINTOMAS O PARA LA PREVENCION Y CONTROL DE DESORDENES NEURODEGENERATIVOS ASOCIADOS O PRODUCTO DE ACTIVACION EXCESIVA DEL COMPLEJO RECEPTOR N UMANOS U OTROS PACIENTES ANIMALES DE SANGRE CALIENTE.
ES92307952T 1991-09-03 1992-09-02 Utilizacion de dicarbamato de 2-fenil-1,3-propanodiol en el tratamiento de enfermedades neurodegenerativas. Expired - Lifetime ES2103347T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75374891A 1991-09-03 1991-09-03

Publications (1)

Publication Number Publication Date
ES2103347T3 true ES2103347T3 (es) 1997-09-16

Family

ID=25031987

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92307952T Expired - Lifetime ES2103347T3 (es) 1991-09-03 1992-09-02 Utilizacion de dicarbamato de 2-fenil-1,3-propanodiol en el tratamiento de enfermedades neurodegenerativas.

Country Status (6)

Country Link
EP (1) EP0531105B1 (es)
AT (1) ATE151632T1 (es)
DE (1) DE69219039T2 (es)
DK (1) DK0531105T3 (es)
ES (1) ES2103347T3 (es)
GR (1) GR3023597T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5728728A (en) * 1996-04-10 1998-03-17 Kozachuk; Walter E. Methods of providing neuroprotection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806543A (en) * 1986-11-25 1989-02-21 Board Of Trustees Of The Leland Stanford Junior University Method and compositions for reducing neurotoxic injury
US4978680A (en) * 1989-09-26 1990-12-18 Carter-Wallace, Inc. Method for the prevention and control of epileptic seizure

Also Published As

Publication number Publication date
DE69219039D1 (de) 1997-05-22
DK0531105T3 (es) 1997-05-12
EP0531105B1 (en) 1997-04-16
GR3023597T3 (en) 1997-08-29
DE69219039T2 (de) 1997-07-24
ATE151632T1 (de) 1997-05-15
EP0531105A1 (en) 1993-03-10

Similar Documents

Publication Publication Date Title
EP1064000A4 (en) VITAMIN D AND ITS ANALOGS FOR THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATION DISORDERS
DE122011100057I1 (de) Zusammenfassungen und ihren Verwendung in der Behandlung von neurologischen Krankheiten.
ES2093593T1 (es) Proteinas obesas (ob) recombinantes.
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
FR2703254B1 (fr) Dispositif de traitement thérapeutique d'un tissu pathologique, comportant un cathéter .
GR3025502T3 (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
MXPA03003354A (es) Dispositivos medicos revestidos para el tratamiento de una enfermedad vascular.
BR9813524A (pt) Processos para tratamento de toxicidades associadas com a administração de um agente terapêutico a um mamìfero, para tratamento de toxicidades associadas com a exposição de um mamìfero à terapia de radiação, para tratamento de neuro- ou nefrodistúrbios em um humano, e, para tratamento de distúrbios e sintomas clìnicos associados com diabetes do tipo i ou do tipo ii em um humano
ES2165910T3 (es) Administracion nasal y ocular de cetamina para el tratamiento del dolor y para la desintoxicacion.
NL300174I2 (nl) Toepassing van venlafaxine of een aryloxypropaanamineverbinding voor de bereiding van een geneesmiddel voor de behandeling van incontinentie.
EP1298203A3 (en) Diagnosis and treatment of autoimmune diseases
PT1040830E (pt) Medicamento para doencas neurodegenerativas
ATE135916T1 (de) Hirnaktivitätfördernde zubereitungen
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
GR3032224T3 (en) Therapeutic agent for threatened abortion.
ES2103347T3 (es) Utilizacion de dicarbamato de 2-fenil-1,3-propanodiol en el tratamiento de enfermedades neurodegenerativas.
MD1716C2 (ro) Utilizare a melatoninei pentru tratamentul pacienţilor dependenţi de benzodiazepine
NZ299257A (en) Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
NO994630L (no) Metoder for behandling av vaskulaere sykdommer
PT1235573E (pt) Associacao de riluzole e de gabapentina e sua utilizacao como medicamento no tratamento das doencas motoneuronais
RU93050675A (ru) Способ коррекции психофизиологического состояния человека
Siegel Successful systematic desensitization in a chronic schizophrenic patient
WO2023242772A1 (en) Support device for a therapeutic device
ES2166912T3 (es) Composiciones, que comprenden bismuto y uno o mas agentes antimicrobianos, para el tratamiento y prevencion de trastornos gastrointestinales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 531105

Country of ref document: ES